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In utero exposure to extra vitamin D from
food fortification and the risk of
subsequent development of gestational
diabetes: the D-tect study
Amélie Keller1* , Maria Stougård1, Peder Frederiksen1, Fanney Thorsteinsdottir1, Allan Vaag2, Peter Damm3,4,
Ramune Jacobsen1,5 and Berit L. Heitmann1,6,7,8
Abstract
Background: The primary aim of this study was to assess whether exposure during fetal life to extra vitamin D
from food fortification was associated with a reduction in the risk of subsequently developing gestational diabetes
mellitus (GDM). Furthermore, we examined whether the effect of the vitamin D from fortification differed by
women’s season of birth.
Methods: This semi-ecological study is based on the cancellation in 1985 of the mandatory policy to fortify
margarine with vitamin D in Denmark, with inclusion of entire national adjacent birth cohorts either exposed or
unexposed to extra vitamin D in utero. The identification of GDM cases later in life among both exposure groups
was based on the Danish national health registers. Logistic regression analyses generating odds ratios (ORs) and
95% confidence intervals (95% CIs) were performed.
Results: Women who were prenatally exposed to the extra vitamin D from fortification tended to have a lower risk
of subsequently developing GDM than unexposed women (OR 0.87, 95%CI 0.74,1.02, P = 0.08). When analyses were
stratified by women’s season of birth, exposed women born in spring had a lower risk of developing GDM
compared to unexposed subjects (OR 0.68, 95%CI 0.50,0.94, p = 0.02).
Conclusion: This study suggests that prenatal exposure to extra vitamin D from mandatory fortification may lower
the risk of developing gestational diabetes among spring-born women.
Trial registration: This study is part of the D-tect project, which is registered on clinicaltrials.gov: NCT03330301.
Keywords: Vitamin D, Gestational diabetes mellitus, Public health epidemiology, Fetal programming, Food intake
Background
Gestational diabetes mellitus (GDM) is defined as
“carbohydrate intolerance of varying severity with onset
or first recognition during pregnancy” [1]. In Europe,
GDM is one of the most common pregnancy disorders
with an estimated prevalence of 2–6% [2]. Women who
develop GDM are more likely to experience pregnancy
related complications such as pregnancy induced hyper-
tension, obstructed labor and macrosomic newborns
(birth weight > 4000 g) and have a high risk of later de-
veloping type 2 diabetes (T2D) [3]. Furthermore, off-
spring of GDM mothers are at increased risk of
metabolic syndrome, GDM, T2D, obesity and cardiovas-
cular disease later in life [2].
Obesity, increased maternal age, family history of T2D
and previous delivery of a macrosomic infant are all
known risk factors for GDM [4]. Nutritional risk factors
such as high red and processed meat consumption as
well as low-fiber and high glycemic index diets may in-
crease the risk of GDM [5, 6]. In regards to the role of
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vitamin D on the risk of GDM development, discrepant
evidence is present in the literature [7, 8], however re-
cent evidence suggests that low blood vitamin D level
during pregnancy could increase the risk of GDM, and
vitamin D supplementation during pregnancy could im-
prove GDM condition [9]. Vitamin D is a fat-soluble
vitamin and a secosteroid obtained either from the diet
(as D2 from vegetables and D3 from food such as oily
fish and dairy products or fortified food and supple-
ments); or through subcutaneous synthesis by exposure
to sunlight [10]. The presence of nuclear vitamin D re-
ceptors and the vitamin D-activating 1-α-hydroxylase
enzyme in the placenta suggests that vitamin D plays an
important role during pregnancy [4] and may influence
fetal development. Moreover, studies have also shown
that low fetal or infancy vitamin D may influence later
risk of disease development, such as type 1 diabetes
(T1D) and pre-eclampsia, via so called early program-
ming [11, 12]. However, no previous studies have exam-
ined if women with a lower fetal vitamin D exposure
may be at higher subsequent risk of developing GDM
than women with a higher fetal exposure to vitamin D.
In Denmark, fortification of margarine with vitamin A
and D started in 1937 [13], and fortification with vitamin
D was stopped by law on the 1st June 1985 [12, 14]. Be-
tween 1962 and 1985, margarine was fortified with
1.25 μg vitamin D/100 g of margarine, representing up
to 29% of total dietary vitamin D intake (average 13%)
[15]. To assess the association between exposure to extra
vitamin D from food fortification in utero and the subse-
quent risk of developing GDM, all women born in
Denmark two years prior and two years after the termin-
ation of the vitamin D fortification were included in this
study. The primary aim of this study was to assess
whether exposure during fetal life to extra vitamin D
from food fortification was associated with a decreased
risk of subsequently developing GDM. Furthermore, we
examined whether the effect of the margarine fortifica-
tion differed by women’s season of birth.
Method
Data sources
The Danish Civil Registration System (CRS) was used to
retrieve information about the study population. Since
April 1968, all people living in Denmark are registered
by a 10-digit civil person registration (CPR) number in
the CRS. Using this number, linkage of individual infor-
mation from different registers and databases was pos-
sible. Information about antenatal care visits for all
women with permanent residence in Denmark has been
registered in the Danish Medical Birth Register (DMBR)
since 1973 [16]. Since 1977, all non-psychiatric hospitals’
discharges, and since 1995, all emergency and outpatient
departments’ discharges have been registered in the
Danish National Patient Register (DNPR) [17]. Thus,
using the CPR, information about pregnancy and off-
spring characteristics were retrieved from the DMBR,
and the DNPR was used to identify diagnoses of GDM
using the International Classification of Diseases (ICD)
10 code 024.4.
Study population
All women born in Denmark around the fortification
termination, between June 1983 and August 1988 and
who later gave birth were included in this study. Based
on the termination of the margarine fortification policy
on the 1st June 1985, women born between June 1983
and May 1985 were considered to have been prenatally
exposed to extra vitamin D. To ensure the unexposed
group was truly unexposed, a 15-month wash-out period
was introduced, from June 1985 to September 1986, ac-
counting for the 9 months of pregnancy and an add-
itional 6 months to ensure vitamin D fortified margarine
was no longer available on the Danish market or house-
holds. Thus, women born between September 1986 and
August 1988 were considered to be unexposed (Fig.1).
The main analyses were restricted to nulliparous women
who gave birth for the first time to a singleton infant be-
tween January 2004 and February 2016 after at least
22 weeks of gestation. In addition, women had to be be-
tween 20.6 and 27.5 years of age at time of delivery, to en-
sure same length of follow-up in both exposure groups.
Therefore, women were excluded from the analyses if they
had missing information on the following variables: age at
delivery, whether it was a singleton or multiple births and
offspring’s gestational age at delivery. Furthermore, women
who were born during the 15-month’s wash-out period
were excluded. Women with a pre-pregnancy BMI ≤15
or ≥ 50 kg/m2 were also excluded as erroneous data-entry
in the DMBR was likely. Women whose own birth weight
was registered as 0 g in the DMBR were also excluded as
this likely reflected erroneous data entry in the DMBR.
Outcome
In 2003, new national recommendations for screening
and treatment of GDM, were implemented which im-
proved GDM detection and management [18]. Since, se-
lective screening for GDM has been recommended in
Denmark to women with at least one of the following
risk factors for GDM: previous GDM, previous birth to a
large child (birth weight ≥ 4500 g), a pre-pregnancy body
mass index (BMI) ≥27 kg/m2, a family history of
diabetes, and glucosuria [18]. A 75 g 2-h oral glucose
tolerance test (OGTT) is performed at 27–30 weeks and
also in early pregnancy (14–20 weeks) for women with
glucosuria, previous GDM or more than one of the
aforementioned risk factors. The diagnostic criteria for
GDM are a 2-h capillary blood or venous plasma glucose
Keller et al. Nutrition Journal          (2018) 17:100 Page 2 of 9
≥9 mmol/L [18]. To ensure GDM diagnosis was harmo-
nized all over Denmark, GDM diagnoses from 1st Janu-
ary 2004 and onwards were included in this study.
Covariates
Information on smoking status during pregnancy, age at
time of delivery, birth weight, pre-pregnancy BMI, singleton
and multiple births, offspring gender, gestational age and
parity were retrieved from the DMBR. Since 1997, data on
smoking habits of pregnant women were collected in the
DMBR. Smoking status during pregnancy was categorized
into current smokers, former smokers (women who
stopped smoking during or after the first trimester in the
current pregnancy) and non-smokers. Pre-pregnancy BMI,
based on self-reported height and weight at the first ante-
natal visit, was included in the DMBR since 2004.
Pre-pregnancy BMI was categorized into the four following
categories: underweight < 18.5 kg/m2, normal weight 18.5–
24.9 kg/m2, overweight 25.0–29.9 kg/m2, obese ≥30 kg/m2.
Women’s birth weight was categorized as follow: < 2500 g;
2500-4000 g; > 4000 g [19]. Offspring’s gestational age at
delivery was categorized based on weeks + days as follow:
< 37, 37 + 0 to 37 + 6, 38 + 0 to 38 + 6, 39 + 0 to 39 + 6, 40
+ 0 to 40 + 6, 41 + 0 to 41 + 6 and ≥ 42 complete weeks of
gestation [12]. Furthermore, size for gestational age (small
for gestational age (SGA) (birth weight < 10th centile for
gestational age and gender) and large for gestational age
(LGA) (birth weight > 90th centile for gestational age and
gender)) using Danish references was assessed [20].
Seasonality of birth in exposed/unexposed women was de-
fined according to month of birth: Winter-born: November
through January; Spring-born: February through April;
Summer-born: May through July; Autumn-born: August
through October. This categorization was based on the sea-
sonal variation in serum 25(OH)D concentration among in-
dividuals from countries in northern latitudes [21].
Statistical analyses
This study used entire birth cohorts of all women who
were born in adjacent years around the termination of
margarine fortification with vitamin D. As the women
were unselected and, for their age, generally representa-
tive of the Danish population of women, in relation to
both exposure status and development of GDM, we hy-
pothesized that adjustment for covariates was not neces-
sary. To confirm this hypothesis, a causal diagram, the
directed acyclic graph (DAG), was used to identify pos-
sible confounders and to build the statistical regression
analyses models [22]. Year of birth (as a proxy for expos-
ure to vitamin D fortified margarine) was put into the
model as the exposure of interest and GDM was the
outcome variable of interest. The covariates mentioned
above were put into the models as potential con-
founders. The presence or absence of a direct associ-
ation between each variable-pair was assessed using a
scientific framework built on theoretical and biological
evidences from the literature [23]. This stepwise
approach was used to draw a DAG on dagitty.net
Females born in Denmark around the fortification event June 1983 – August 1988   
N 162,397  
Births by women born around the fortification event - June 1983 – August 1988     
N 112,311
Excluded births
1
N 27,003
Analyzed unexposed nulliparous women aged aged 20.6 – 27.5 years
n 14,855
Analyzed exposed nulliparous women aged 20.6 – 27.5 years 
n 14,016
Excluded births
3
n 8,107
Excluded births
3
n 8,404
Births January 2004 to November 2012 by exposed women aged 20.6 – 27.5
years & born between June 1983 to May 1985
n 22,123
Births April 2007 to February 2016 by unexposed women aged 20.6 – 27.5
years & born between September 1986 to August 1988
n 23,259
Births from January 2004 to March 2016 by women born from June 1983 – August 1988   
N 85,308
Gestational diabetes among nulliparous exposed women
n 297 (2.1
Gestational diabetes among nulliparous unexposed women
n 361 (2.4
)
)
Excluded births
2
N 39,926
Fig. 1 Flow chart of the study population, 1Exclusion criteria: Women born during the 15 months’ wash-out period from June 1985 to August
1986. 2Exclusion criteria: Women < 20.6 and > 27.5 years old or missing. 3Exclusion criteria: gestational weeks was < 22 weeks or missing,
pre-pregnancy BMI was < 15 kg/m2 or > 50 kg/m2, women’s own birth weight was 0 g, multiple births, stillbirths, multiparous women
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(Online-Only Additional file 1: DAG), from which the
following statistical models were developed:
 Crude model: no adjustment
 Model 1: adjustment for women’s season of birth
Chi-squared test was used to test the differences be-
tween exposed and unexposed women for categorical
variables and Mann-Whitney rank-sum test for skewed
continuous data. Test for normality was not performed
for age distribution, as it was a priori skewed because of
the age restriction applied. The association between fetal
exposure to vitamin D fortified margarine and the risk of
developing GDM was examined by logistic regression
generating odds ratios (ORs) and 95% confidence in-
tervals (95% CIs). The effect of the vitamin D fortifi-
cation on the fetus was expected to have most effect
when stores are low, such as winter pregnancies;
therefore, to evaluate whether women’s season of
birth modified the association between prenatal vita-
min D exposure and GDM, stratified analyses by
women’s season of birth were performed.
Sensitivity analyses
The prevalence of GDM has increased over the years and is
higher at increased maternal age [24]. Therefore, trends in
GDM incidence by maternal age, women’s year of birth and
offspring’s year of birth were tested using Chi-squared test.
Prevalence of overweight and obesity among women
of childbearing age, smoking habits during pregnancy
and age at delivery have changed over time, and thus
might have been different between exposed and unex-
posed women in this study. Therefore, sensitivity ana-
lyses adjusted for women’s pre-pregnancy BMI, smoking
status in pregnancy and age at delivery were performed
(Online-Only Additional file 1: Tables S1–S3).
The amount of bright sunshine hours during pregnancy
has previously been reported to be an important variable
to be adjusted for while analyzing exposure-outcome asso-
ciation in a similar setting [11], therefore, sensitivity ana-
lyses adjusted for total and trimestral gestational sunshine
hours were performed. The data on bright sunshine hours
were obtained from the Danish Meteorological Institute
(DMI) [25]. Summary monthly sunshine hours during the
nine months prior to the month of birth, bounded to each
individual were calculated. First, second and third trimes-
ter sunshine hours were also calculated by summing
recoded monthly sunshine hours during 1st, 2nd and 3rd
thirds of these 9 months, respectively [11] (Online-Only
Additional file 1: Tables S4a–S4 h).
Women born during the 15-month wash-out period were
gradually less exposed to vitamin D from the fortified mar-
garine. To test the additional hypothesis that these women
have a higher risk of developing GDM than the exposed
women, and a lower risk than the unexposed women, ana-
lyses with the three exposure groups were additionally per-
formed (Online-Only Additional file 1: Tables S5a –S5b).
The statistical software package Stata 13 (StataCorp LP,
College Station, Texas, 2013; https://www.stata.com/) was
used for all data management and analyses. A level of sig-
nificance as defined through p-values p < 0.05 was used.
Results
There were 297 (2.1%) cases of GDM among women
who were prenatally exposed to vitamin D fortified mar-
garine (N = 14,016) compared to 361 (2.4%) GDM cases
among the unexposed (N = 14,855) (p = 0.08) (Fig. 1). Ma-
ternal age at delivery was statistically slightly higher but the
difference being clinically not relevant among the exposed
compared to the unexposed with a median (5; 95 percen-
tiles) of 25.2 (21.4; 27.3) and 25.1 (21.2; 27.3) years, respect-
ively (p < 0.0001). Unexposed women were more likely to
be former smokers and non-smokers compared to exposed
women (5.6% vs. 5.2% and 81.3% vs.79.1%, respectively).
Exposed women more often gave birth after 42 weeks of
gestation (6.0% vs. 3.4%), and slightly more often had a
pre-pregnancy BMI between 18.5 and 25 kg/m2 than unex-
posed women (60.7% vs. 59.6%) (p = 0.01). There was no
difference in the distribution of the women’s season of birth
between the two exposure groups (p = 0.8). Women born
between 1983 and 1985 were exposed to more hours of
bright sunshine during gestation than women born after
the vitamin D fortification termination, median (5; 95 per-
centiles) 1108 (752;1311) and 1004 (772;1320) hours re-
spectively (p < 0.0001) (Table 1).
Women prenatally exposed to the vitamin D fortification
tended to have a lower risk of developing GDM than
unexposed women (Crude model: OR 0.87, 95%CI
0.74,1.02, p = 0.08; Model 1: OR 0.87, 95%CI 0.74,1.02, P =
0.08) (Table 2). Further adjustment for women born SGA
or LGA to account for differences in birth weight adjusted
for gestational age gave essentially similar results (data not
shown). When analyses were stratified by women’s season
of birth, exposed women born in spring (winter pregnan-
cies) had a lower risk of developing GDM compared to
those unexposed to extra vitamin D (OR 0.68, 95%CI
0.50,0.94, p = 0.02) (Table 3).
Results from sensitivity analyses were essentially simi-
lar to the main results (Online-Only Additional file 1:
Tables S1-S4). Women born during the wash-out period
tended to have a higher risk of developing GDM
compared to exposed women (Crude model: OR 1.18,
95%CI 0.99,1.40, p = 0.07; Model 1: OR 1.17, 95%CI
0.98,1.40, p = 0.08) and a similar risk compared to the
unexposed women (Crude model: OR 1.02, 95%CI
0.87,1.21, p = 0.78; Model 1: OR 1.02, 95%CI 0.86,1.21, p =
0.83), however the differences were not significant (Onli-
ne-Only Additional file 1: Tables S5a –S5b).
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There was a higher GDM incidence with higher age at
delivery (p = 0.004), and both women’s (p = 0.04) and off-
spring’s years of birth (p < 0.0001).
Discussion
This study suggests that prenatal exposure to extra
vitamin D from mandatory fortification may lower the
Table 1 Characteristics of women prenatally exposed and unexposed to vitamin D fortified margarine and their offspring
Exposed Unexposed p-value
N Median (5,95 percentiles) N Median (5,95 percentiles)
Age at deliverya,c 14,016 25.2 (21.4;27.3) 14,855 25.1 (21.2;27.3) < 0.0001
Gestational sunshine hoursa,c,e 14,016 1108 (752;1311) 14,855 1004 (772;1320) < 0.0001
Offspring’s birth weight (g) b,d 14,016 3460 (2572;4270) 14,855 3455 (2560;4260) 0.3
Percentage Percentage
Gestational diabetes mellitusa 297 2.1 361 2.4 0.08
Pre-pregnancy BMIa,d 0.01
< 18.5 kg/m2 636 4.5 800 5.4
18.5–24.9 kg/m2 8514 60.7 8860 59.6
25–29.9 kg/m2 2984 21.3 3154 21.2
≥ 30 kg/m2 1882 13.4 2041 13.7
Size for gestational agea 0.7
SGA 1741 12.4 1891 12.7
NGA 11,299 80.7 11,961 80.6
LGA 955 6.8 990 6.7
Birth weight (g)a,d 0.8
< 2500 570 4.1 593 4.0
2500–4000 11,536 82.3 12,274 82.6
≥ 4000 1910 13.6 1988 13.4
Smoking status during pregnancya,d < 0.0001
Current smoker 2170 15.8 1911 13.0
Former smoker 715 5.2 827 5.6
Non-smoker 10,890 79.1 11,935 81.3
Season of birthd 0.8
Winter 3214 23.0 3465 23.3
Spring 3568 25.5 3722 25.1
Summer 3675 26.2 3875 26.1
Autumn 3559 25.4 3793 25.5
Offspring’s gestational age at delivery (weeks)b,d < 0.0001
< 37 871 6.2 892 6.0
37 + 0–37 + 6 699 5.0 727 4.9
38 + 0–38 + 6 1688 12.0 1751 11.8
39 + 0–39 + 6 3068 21.9 3150 21.2
40 + 0–40 + 6 4033 28.8 4423 29.8
41 + 0–41 + 6 2819 20.1 3414 23.0
≥ 42 838 6.0 498 3.4
Offspring’s genderb,d 0.02
Female 6920 49.4 7128 48.0
Male 7096 50.6 7727 52.0
aCharacteristics of women prenatally exposed and unexposed to vitamin D fortified margarine and b their offspring
ctested by Mann-Whitney rank-sum test and d tested by X2-test
eSummary monthly sunshine hours during the nine months prior to the month of birth, bounded to each individual
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risk of developing gestational diabetes among
spring-born women. This finding suggests that the
extra vitamin D from fortification may have been of
particular benefit to offspring of mothers who were
pregnant during most of the dark months when vita-
min D skin synthesis is low or null, and when diet or
supplementation are the sole sources of vitamin D.
Few previous studies have examined association be-
tween early exposure to vitamin D and the development
of diabetes later in life. One previous longitudinal study
found an association between low concentrations of
25(OH)D in pregnant mothers and fasting insulin con-
centrations and insulin resistance in their children at
9.5 years of age [26]. As glucose homeostasis variables
tend to track from childhood to adulthood [27],
25(OH)D concentration during fetal life might also
influence glucose homeostasis variables in childhood
and may predict the development of diabetes in adult-
hood. In regards to T1D, a meta-analysis has con-
cluded that vitamin D supplementation in early
childhood may be associated with a lower risk of de-
veloping of T1D [28]; however, the risk of developing
T1D was not different for subjects exposed and unex-
posed to extra vitamin D from fortified margarine in
our previous study [29]. The discrepant findings
between exposure to vitamin D fortification during fetal
life on the risk of developing T1D and GDM might be due
to a possible different genetic-environmental risk factors
ratio between the two diseases; GDM being more suscep-
tible to lifestyle related risk factors than T1D.
Several potential mechanisms could explain our find-
ing of a potential protective effect of exposure to vitamin
D in early life on the subsequent development of GDM.
Multiple factors affecting early growth may induce
changes in the structure and function of certain organs
and tissues such as the pancreas [30]. Results from ani-
mal models suggest that maternal vitamin D restriction
may lead to insulin dysregulation inducing a compensa-
tory increase in pancreatic beta-cell mass in the off-
spring [30]. Another mechanism might be related to the
mediating role of vitamin D on the association between
amino acids supply and fetal growth [31]. Animal
models suggest that maternal protein restriction may
cause chronic disease in adulthood among first and sec-
ond offspring generations [30]. Already in 1992, Hales &
Barker stated that β-cell growth and development as well
as insulin secretion until late fetal life are controlled by
amino acids supply [32]. Therefore, an unanswered
question is whether vitamin D may be involved in the
amino acids supply to the fetus. A recent human study,
suggested that placental amino acid transport may be
regulated by maternal vitamin D and vitamin D-binding
protein [33]. Hence, exposure to extra vitamin D during
fetal life may promote adequate β-cell growth by mediat-
ing placental amino acid transport and decrease the risk
of developing diabetes in later life [33]. Moreover, vitamin
D supply might be especially important during the second
gestational trimesters as animal studies have confirmed
that it is an important period for development and bio-
chemical maturation of β-cells, however these findings
were not confirmed in a human study [34].
There is increasing evidence for a potential role of in-
flammation in the pathogenesis of T2D and GDM [35].
During pregnancy, vitamin D receptors and 1,25(OH)2D3
have been described to play a role in the adaptive and in-
nate immune system as well as in the secretion of insulin
by the pancreatic β-cells [36]. Therefore, exposure to extra
gestational vitamin D might reduce the risk of GDM by
modulating the innate immune system, particularly when
vitamin D skin synthesis is low or absent. From 1937 to
1985, margarine was fortified with both vitamins D and A;
and from 1985 only with vitamin A [12]. Therefore, the
potential protective effect of in utero exposure to vitamin
D fortified margarine on the development of GDM seen
in this study may be due to additive, synergistic or antag-
onist interactions between vitamins A and D. It has been
reported that both vitamins may be involved in the
development and functioning of human fetal pancreas.
However, more studies are needed to explain these
Table 2 Crude and adjusted odds ratio (OR) and 95%
confidence intervals (95%CI) for gestational diabetes mellitus
among women prenatally exposed and unexposed to vitamin D
fortified margarine
Exposure Crudea Model 1a
N OR 95%CI p-value OR 95%CI p-value
Unexposed 14,855 1 1
Exposed 14,016 0.87 0.74, 1.02 0.08 0.87 0.74, 1.02 0.08
aCrude model: no adjustment; Model 1a: adjustment for women’s season of birth
Table 3 Crude odds ratio (OR) and 95% confidence intervals
(95%CI) for gestational diabetes mellitus among women
prenatally exposed and unexposed to vitamin D fortified
margarine stratified by women’s season of birth
Seasons
of birtha
N % GDM Crude
Exposure OR 95%CI p-value
Winter Unexposed 3465 2.3 1
Exposed 3214 2.3 0.98 0.71, 1.35 0.92
Spring Unexposed 3722 2.6 1
Exposed 3568 1.8 0.68 0.50, 0.94 0.02
Summer Unexposed 3875 2.5 1
Exposed 3675 2.0 0.83 0.61, 1.13 0.23
Autumn Unexposed 3793 2.4 1
Exposed 3559 2.4 1.02 0.75, 1.38 0.91
aWinter: November to January; Spring: February to April; Summer: May to July;
Autumn: August to October
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mechanisms and their potential role in the development
of diabetes in humans [14].
Methodological considerations
This study is the first to examine if fetal exposure to
extra vitamin D may influence GDM development. The
inclusion of all women from entire birth cohorts of the
whole Danish population was made possible by the
complete registration of every citizen via a CPR number
into the Danish national health registers. By separating
women from exposure groups by a specific point in
time, selection bias was minimized. However, residual
confounding cannot be excluded and in the following
sections several potential confounders are discussed.
Age at delivery
Older women have a higher risk of developing GDM
[24] and in this study we also saw a linear association
between higher risk of GDM and older age at delivery.
Age at delivery in our study was slightly higher in ex-
posed compared to unexposed women, which advocated
for a true association between the prenatal exposure to
vitamin D fortification and GDM risk. However, women
included in this study were relatively young and are not
representative of all women that develop GDM.
Trends in birth weight
Increased birth weight has been associated with later on-
set of GDM [37]. However, no secular trend in birth
weight between 1983 and 1988 were seen in this study
(Online-Only Additional file 1: Table S6).
Overweight and obesity
The prevalence of overweight and obesity, which are
strong risk factors of GDM [4], is increasing among
women of childbearing age, particularly among young
women [38]. Our sensitivity analyses that adjusted for
pre-pregnancy BMI gave similar results as analyses with-
out adjustment, suggesting that maternal BMI was not
associated with the development of GDM in the present
study. However, residual confounding related to fat mass
or fat distribution, which we did not have information
on, is still a possibility.
Diet and vitamin D supplementation
No significant changes in margarine consumption in
Denmark in the period analyzed have been reported
[39]. Furthermore, there were no changes in recommen-
dations regarding vitamin D intake or vitamin supple-
mentation during pregnancy between 1983 and 1988
[12]. Therefore, it is unlikely that these factors influ-
enced our results.
Bright sunshine hours as a source of vitamin D
Sensitivity analyses including adjustment for individual
bright sunshine hours showed similar results as the main
analyses without adjustment, suggesting that the effect
of the vitamin D fortification during gestation on later
risk of GDM observed in this study was not confounded
by vitamin D synthesized in the skin.
Smoking
We did not have data on smoking by the mothers of the
women included, however, it is estimated that about 40%
of all women smoked during pregnancy between 1983
and 1993 [40], and that the proportion of smokers, thus,
did not differ between the exposed and unexposed
group. On the other hand, the prevalence of women
smoking during pregnancy has since been decreasing
[41], and as smoking has been shown to be associated
with GDM risk [42], such change in smoking habits
might have influenced our results. However, sensitivity
analyses adjusted for pregnancy smoking habits showed
similar results as analyses without adjustment, suggest-
ing that smoking during pregnancy did not confound
the association observed.
Assisted reproductive technology (ART)
In Europe, the use of ART has been increasing over the
years and an increased risk of GDM following ART
treatment has been reported [43]. The chance that
women conceived with the help of ART in our study
was most likely slightly larger for unexposed than ex-
posed women, and hence the use of ART could poten-
tially have confounded the association observed.
However, most women undergoing ART treatment in
Denmark are over 30 years old and in the present study
the oldest women were 27.5 years at time of delivery.
Therefore, the risk of potential confounding by ART is
expected to be minimal.
Induced labor
A more aggressive policy towards inducing delivery after
41+ weeks was introduced in Denmark around 2009
[44], potentially leading the unexposed group to have
less “time in pregnancy” to develop/or have a diagnosis
of GDM. However, GDM is rarely diagnosed after term
since routine screening is generally performed at the lat-
est at 27–30 weeks of gestation [18]. When analyses
were restricted to women delivering before 41 weeks of
gestation, similar results were found (data not shown).
GDM prevalence
In Denmark, the prevalence of GDM is relatively low on
a global scale and has increased from 1.7 to 2.9% be-
tween 2004 and 2012 [24]. Therefore, although the
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difference between the two exposure groups (2.1% vs.
2.4%) may seem small, it might still be clinically
relevant.
In this study, GDM risk increased with women’s year
of birth: from 2.0% in those born in 1983 to 2.9% in
those born in 1988. This suggests that secular trends in
GDM risk in Denmark may be present, making it diffi-
cult to disentangle the specific effects related to vitamin
D fortification.
GDM at subsequent pregnancies
Women who develop GDM during their first pregnancy
are at increased risk of developing GDM in their subse-
quent pregnancies [3]. Therefore, analyses to examine
the risk of GDM in the second pregnancy, conditional
on whether GDM was present in the first pregnancy,
among women with two pregnancies, was planned.
However, no women met the criteria.
Diagnosis of GDM
The diagnostic criteria for GDM did not change during
the study period and by using the DMBR and DNPR, se-
lection bias and risk of loss to follow-up could be
avoided. Universal health coverage in Denmark secures
that all Danish residents have access to healthcare re-
gardless of their ethnic background or socioeconomic
status. All deliveries, either at hospitals or at home with
a midwife attending from the regional hospitals, are re-
corded in the registers. Therefore, most GDM diagnoses
are registered in the DNPR.
Finally, we cannot exclude that other environmental
and/or societal changes, such as an increase in the ex-
posure to endocrine disrupting chemicals [45], may have
influenced our results for instance through epigenetic
changes influencing lifelong health and disease by modi-
fying inflammatory molecular pathways and the immune
response [46].
Conclusion
This study suggests that prenatal exposure to extra vita-
min D from mandatory fortification may lower the risk
of developing gestational diabetes among spring-born
women, eg. from winter pregnancies, when the small
extra amount of vitamin D from fortification seemed
particularly beneficial.
Our results may have public health relevance as they
demonstrate that mothers consuming extra vitamin D
from food fortification had daughters who were at lower
subsequent risk of developing GDM. However, recom-
mendations for vitamin D supplementation or fortifica-
tion cannot be provided on the basis of this study and
would require long-term randomized controlled trials.
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